Quick Links
Resources
About MyMyelomaTeam
Powered By
Has Anyone Heard About This New Medication??? See Below
On Tuesday, Johnson & Johnson(JNJ) announced results from a prespecified second interim analysis of Phase 3 CARTITUDE-4 study evaluating Carvykti (ciltacabtagene autoleucel; cilta-cel) compared to standard therapies of pomalidomide, bortezomib, and dexamethasone or daratumumab, pomalidomide, and dexamethasone for relapsed or lenalidomide-refractory multiple myeloma after one prior line of therapy
In simple words, the study compared Carvykti, a treatment for multiple myeloma, to other standard… read more
I didn't ask aquestion about depression. I made a comment on a new myeloma drug and attached the answer to a reply. The new drug is Phase 3 CARTITUDE-4 study evaluating Carvykti (ciltacabtagene autoleucel; cilta-cel)
MyMyelomaTeam started using AI to help answer questions. Sometimes it makes a mistake.
Thank you for posting information about a new drug.
Paula🌹
What has AI got to do with the comment copied to the Team? That information came directly from Johnson & Johnson. Clear up with a note to me please.
I typed, “It’s NOT a real person”, and somehow my IPad changed MY typing! Hilarious!
Paula 🌹
Dan,
This is an AI response so your question. It a real person.
Anxiety
How To Manage Mentally With This Illness As The Life You Knew Has Changed So Much.
Hello MM Family What Is The Difference Between Remission And Cancer Free? Are They Consider The Same. Please Give Feedback.
Sign up for free!
Continue with Facebook
Sign up with your email
